Skip to main content
VCbacked
Log inGet Started

OMass Therapeutics

Oxford, United Kingdom

OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.

$12.5M raised
May 2023
Series B
Life SciencePharmaceutical

Top Investors

Oxford Science EnterprisesGoogle VenturesNorthpond VenturesUniversity of OxfordSanofi Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about OMass Therapeutics

How much funding has OMass Therapeutics raised?
OMass Therapeutics has raised $12.5M in total funding. The most recent round was Series B. The last funding was announced in May 2023.
Who are OMass Therapeutics's investors?
OMass Therapeutics's investors include Oxford Science Enterprises, Google Ventures, Northpond Ventures, University of Oxford, Sanofi Ventures.
Where is OMass Therapeutics headquartered?
OMass Therapeutics is headquartered in Oxford, United Kingdom.
What does OMass Therapeutics do?
OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.
What stage is OMass Therapeutics at?
OMass Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"OMass Therapeutics — Funding & Investors." VCBacked, May 15, 2023, https://www.vcbacked.co/company/omass-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2023). OMass Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/omass-therapeutics
Wikipedia (cite web)
{{cite web |title=OMass Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/omass-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Life Science

View all
Pharvaris
Zug
Sedivention
Munich$848K
Modicus Prime
Austin
Kanvas Biosciences
Monmouth Junction$12.5M
Dandelion Health AI
New York$15.9M
Quiver Bioscience
Cambridge